Accessibility Menu

Is Shire's Dividend Safe?

Shire is losing patent protection on a key ADHD drug this year, but should dividend investors be concerned?

By Todd Campbell Jun 23, 2014 at 5:30PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.